Leukemia, Hairy Cell - 25 Studies Found
Completed |
: Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab : Hairy Cell Leukemia (HCL) : 2014-05-21 : Drug: 2CdA +/- Rituximab Cladribine 0.14 mg/kg daily subcutaneous bolus injection Rituximab 375 mg/m |
Completed |
: A Phase I, Multicenter Dose Escalation Study in Patients With Leukemia : Hairy Cell Leukemia : 2007-12-21 : Biological: CAT 8015 (Moxetumomab Pasudotox) The dose level of the initial cohort will be 5 μg/kg s |
Completed |
: BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia : Leukemia : 2003-12-10 : Drug: BL22 Dosing via IV on Days 1,3, and 5. |
Completed |
: Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia : Leukemia : 2000-05-02 :
|
Completed |
: Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy : Leukemia : 1999-11-01 : Biological: rituximab |
Completed |
: Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia : Leukemia : 1999-11-01 :
|
Recruiting |
: 2CDA With Rituximab in Hairy Cell Leukemia : Leukemia : 2006-12-14 :
|
Recruiting |
: Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease :
|
Recruiting |
: Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes : Leukemia, Other : 2015-08-20 |
Completed |
: Immunotoxin Therapy in Treating Patients With Hairy Cell Leukemia : Leukemia : 2001-08-10 : Biological: BL22 immunotoxin |